Snapshot

Amebocyte Lysate is an aqueous extract of blood cells from the Atlantic horseshoe crab or oriental horseshoe crab. Amebocyte Lysate reacts with bacterial endotoxin lipopolysaccharide (LPS), which is a membrane component of gram negative bacteria. This reaction is the basis of the Amebocyte Lysate test, which is then used for the detection and quantification of bacterial endotoxins.
The global Amebocyte Lysate market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Amebocyte Lysate by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Limulus Amebocyte Lysate
Tachypleus Amebocyte Lysate

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Charles River Laboratories
LONZA
Associates of Cape Cod
Xiamen Bioendo Technology
Zhanjiang A&C Biological
Zhanjiang Bokang
Fuzhou Xinbei

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Drug Testing
Clinical Diagnosis
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)